uOttawa’s Dr. Doug Manuel and a team of Canadian researchers have built and validated an online calculator that empowers individuals to predict their risk of cardiovascular disease. Their process was published July 23 in the CMAJ.
uOttawa’s Dr. Doug Manuel and a team of Canadian researchers have built and validated an online calculator that empowers individuals to predict their risk of cardiovascular disease. Their process was published July 23 in the CMAJ.
Damien D’Amours and team explore how disruptions during cell duplication can alter DNA, potentially leading to cancer, immunodeficiency, aging and other effects.
Damien D’Amours and team explore how disruptions during cell duplication can alter DNA, potentially leading to cancer, immunodeficiency, aging and other effects.
There is currently no cure for Amyotrophic Lateral Sclerosis (ALS), but new research published in Nature Communications coming out of the Gibbings lab is bringing us closer.
There is currently no cure for Amyotrophic Lateral Sclerosis (ALS), but new research published in Nature Communications coming out of the Gibbings lab is bringing us closer.
Metabolomics applies sophisticated technologies to assess the body’s metabolites, reflecting its activities and aiding in the understanding of healthy and diseased states.
Metabolomics applies sophisticated technologies to assess the body’s metabolites, reflecting its activities and aiding in the understanding of healthy and diseased states.
